For actionable tumor insights from FFPE and liquid biopsy samples
Designed to enrich for the genes and variants most relevant to your research
Proven performance with the GeneReader NGS System
Verified for use with DNA from FFPE samples and liquid biopsy samples
The first panel to be integrated as part of a complete end-to-end NGS workflow
The GeneRead QIAact Actionable Insights Tumor Panel was designed using the comprehensive and continuously updated QIAGEN Knowledge Base. The panel content has also been validated extensively with well-recognized US and European experts who have been conducting cancer research using NGS. The resulting design is a unique set of 747 variant positions in 12 genes for use with FFPE and liquid biopsy samples. With an unparalleled level of direct relevance you can have confidence in achieving actionable insights into only the most important variants for your research.